To test the hypothesis of YAP1 involvement in TP53 mutation-mediated chemosensitivity, we investigated this mechanism in silico, using the CGGA dataset that includes clinical and transcriptomics data on recurrent gliomas. This evidence concerns the gene YAP1 and glioma.